Literature DB >> 11272193

Regulation of beta-cell mass by hormones and growth factors.

J H Nielsen1, E D Galsgaard, A Møldrup, B N Friedrichsen, N Billestrup, J A Hansen, Y C Lee, C Carlsson.   

Abstract

Substantial new information has accumulated on molecular mechanisms of pancreas development, regulation of beta-cell gene expression, and the role of growth factors in the differentiation, growth, and regeneration of beta-cells. The present review focuses on some recent studies on the mechanism of action of cytokines such as growth hormone (GH) and prolactin (PRL) in beta-cell proliferation and gene expression-in particular, the role of signal transducers and activators of transcription (STAT) proteins. The implication of the discovery of suppressors of cytokine signaling (SOCS) proteins for the interaction between stimulatory and inhibitory cytokines, including GH, PRL, leptin, and the proinflammatory cytokines interleukin-1 and interferon-gamma, in beta-cell survival is not yet clear. Recent studies indicate a role of cell adhesion molecules and the delta-like protein preadipocyte factor 1/fetal antigen 1 (Pref-1/FA-1) in cytokine-induced beta-cell growth and development. Surprisingly, glucagon-like peptide-1 (GLP-1) was recently found to stimulate not only insulin secretion but also beta-cell replication and differentiation, which may present a new perspective in treatment of type 2 diabetes. Together with the intriguing reports on positive effects of insulin on both beta-cell growth and function, a picture is emerging of an integrated network of signaling events acting in concert to control beta-cell mass adaptation to insulin demand.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272193     DOI: 10.2337/diabetes.50.2007.s25

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  60 in total

1.  Immune intervention in children with type 1 diabetes.

Authors:  Johnny Ludvigsson
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

2.  Loss of Foxd3 results in decreased β-cell proliferation and glucose intolerance during pregnancy.

Authors:  Jennifer L Plank; Audrey Y Frist; Alison W LeGrone; Mark A Magnuson; Patricia A Labosky
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

3.  mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability.

Authors:  Norman Balcazar; Aruna Sathyamurthy; Lynda Elghazi; Aaron Gould; Aaron Weiss; Ichiro Shiojima; Kenneth Walsh; Ernesto Bernal-Mizrachi
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

4.  Molecular causes of transcriptional response: a Bayesian prior knowledge approach.

Authors:  Kourosh Zarringhalam; Ahmed Enayetallah; Alex Gutteridge; Ben Sidders; Daniel Ziemek
Journal:  Bioinformatics       Date:  2013-09-26       Impact factor: 6.937

Review 5.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

6.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

7.  Role of endogenous IL-6 in the neonatal expansion and functionality of Wistar rat pancreatic alpha cells.

Authors:  E Fernández-Millán; J de Toro-Martín; E Lizárraga-Mollinedo; F Escrivá; C Álvarez
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

Review 8.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

9.  Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas.

Authors:  Yue J Wang; Maria L Golson; Jonathan Schug; Daniel Traum; Chengyang Liu; Kumar Vivek; Craig Dorrell; Ali Naji; Alvin C Powers; Kyong-Mi Chang; Markus Grompe; Klaus H Kaestner
Journal:  Cell Metab       Date:  2016-10-11       Impact factor: 27.287

10.  Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.

Authors:  Hongjie Zhang; Jia Zhang; Christine F Pope; Laura A Crawford; Rupangi C Vasavada; Shubhada M Jagasia; Maureen Gannon
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.